Gene-environment interactions: Lifetime cognitive activity, APOE genotype, and beta-amyloid burden

Journal of Neuroscience

Volumn 34, Issue 25, 2014, Pages 8612-8617

  Wirth, Miranka ^a   Villeneuve, Sylvia ^a   La Joie, Renaud ^a   Marks, Shawn M ^a   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Aging; Alzheimer's disease; APOE; Lifestyle activity; PIB PET; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; PITTSBURGH COMPOUND B;

ADULT; AGE; AGED; ARTICLE; COGNITION; CORRELATION COEFFICIENT; DEPRESSION; DRUG RETENTION; FEMALE; FOLLOW UP; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GERIATRIC DEPRESSION SCALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LIFESTYLE; LONGITUDINAL STUDY; MALE; MEMORY; NEUROIMAGING; NEUROPSYCHOLOGY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SOCIAL STATUS;

AGING; ALZHEIMER'S DISEASE; APOE; LIFESTYLE ACTIVITY; PIB-PET; Β-AMYLOID;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; BRAIN CHEMISTRY; COGNITION; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; LONGEVITY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 84902455407     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4612-13.2014     Document Type: Article

References (44)

1. Aiken LS, West SG (1991) Multiple regression: testing and interpreting interactions. Newbury Park, CA: Sage Publications.
2. Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, Kong E, Larraburo Y, Rolle C, Johnston E, Gazzaley A (2013) Video game training enhances cognitive control in older adults. Nature 501:97-101. CrossRef Medline
3. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10:819-828. CrossRef Medline
4. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, HoltzmanDM (2011) Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14:750-756. CrossRef Medline
5. Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, Holtzman DM (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321:1221-1224. CrossRef Medline
6. Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, Ames D, Macaulay SL, Szoeke C, Rowe CC, Martins RN (2013) Physical activity and amyloid-beta plasma and brain levels: results from the Australian imaging, biomarkers and lifestyle study of ageing. Mol Psychiatry 18:875-881. CrossRef Medline
7. Carlson MC, Helms MJ, Steffens DC, Burke JR, Potter GG, Plassman BL (2008) Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement 4:324-331. CrossRef Medline
8. Cohen J, Cohen P, West SG, Aiken LS (2003) Applied multiple regression/ correlation analysis for the behavioral sciences, Ed 3. Mahwah, NJ: L. Erlbaum Associates.
9. Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H (2007) Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging 28:831-844. CrossRef Medline
10. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980. CrossRef Medline
11. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 278:1349-1356. CrossRef Medline
12. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A 106:7209-7214. CrossRef Medline
13. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341-355. CrossRef Medline
14. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP (2001) Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153:242-250. CrossRef Medline
15. Gold BT, Kim C, Johnson NF, Kryscio RJ, Smith CD (2013) Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J Neurosci 33:387-396. CrossRef Medline
16. Hauser RM, Warren JR (1997) Socioeconomic indexes for occupations: a review, update, and critique. Soc Methodol 27:177-298. CrossRef
17. Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, Holtzman DM, Morris JC (2012) Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 69:636-643. CrossRef Medline
18. Herring A, Lewejohann L, Panzer AL, Donath A, Kröll O, Sachser N, Paulus W, KeyvaniK (2011) Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Neurobiol Dis 42:530-538. CrossRef Medline
19. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128. CrossRef Medline
20. Jagust WJ, Mormino EC (2011) Lifespan brain activity, beta-amyloid, and Alzheimer's disease. Trends Cogn Sci 15:520-526. CrossRef Medline
21. Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, Hachinski V, Cedazo-Minguez A, Soininen H, Tuomilehto J, Nissinen A (2008) Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med 12:2762-2771. CrossRef Medline
22. Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650-657. CrossRef Medline
23. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ (2012a) Association of lifetime cognitive engagement and low beta-amyloid deposition. Arch Neurol 69:623-629. CrossRef Medline
24. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701-713. CrossRef Medline
25. Liang KY, Mintun MA, Fagan AM, Goate AM, Bugg JM, Holtzman DM, Morris JC, Head D (2010) Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann Neurol 68:311-318. CrossRef Medline
26. Li S, Jin M, Zhang D, Yang T, Koeglsperger T, Fu H, Selkoe DJ (2013) Environmental novelty activates beta2-adrenergic signaling to prevent the impairment of hippocampal LTP by Abeta oligomers. Neuron 77:929-941. CrossRef Medline
27. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-840. CrossRef Medline
28. Lövdén M, Bodammer NC, Kühn S, Kaufmann J, Schütze H, Tempelmann C, Heinze HJ, Düzel E, Schmiedek F, Lindenberger U (2010) Experiencedependent plasticity of white-matter microstructure extends into old age. Neuropsychologia 48:3878-3883. CrossRef Medline
29. Niti M, Yap KB, Kua EH, Tan CH, Ng TP (2008) Physical, social and productive leisure activities, cognitive decline and interaction with APOEepsilon 4 genotype in Chinese older adults. Int Psychogeriatr 20:237-251. CrossRef Medline
30. Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C, et al. (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. J AmGeriatr Soc 55:1777-1785. CrossRef Medline
31. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ (2012) Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals. Arch Neurol 69:223-229. CrossRef Medline
32. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A 101:284-289. CrossRef Medline
33. Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 106:6820-6825. CrossRef Medline
34. Rodrigue KM, Rieck JR, Kennedy KM, DevousMDSr, Diaz-Arrastia R, ParkDC (2013) Risk factors for beta-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol 70:600-606. CrossRef Medline
35. Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G (1978) A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 31:741-755. CrossRef Medline
36. Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack CR Jr (2010) Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol 67:308-316. CrossRef Medline
37. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Roberts RO, Lowe VJ, Kantarci K, Senjem ML, Gunter JL, Boeve BF, Petersen RC, Jack CR Jr (2012) Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol 72:730-738. CrossRef Medline
38. Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA (2002a) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287:742-748. CrossRef Medline
39. Wilson RS, Bennett DA, Bienias JL, Aggarwal NT, Mendes De Leon CF, Morris MC, Schneider JA, Evans DA (2002b) Cognitive activity and incident AD in a population-based sample of older persons. Neurology 59:1910-1914. CrossRef Medline
40. Wilson RS, Segawa E, Boyle PA, BennettDA (2012) Influence of late-life cognitive activity on cognitive health. Neurology 78:1123-1129. CrossRef Medline
41. Wilson R, Barnes L, Bennett D (2003) Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsychol 25:634-642. CrossRef Medline
42. Wirth M, Madison CM, Rabinovici GD, OhH, Landau SM, JagustWJ (2013) Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals. J Neurosci 33:5553-5563. CrossRef Medline
43. Woodard JL, Sugarman MA, Nielson KA, Smith JC, Seidenberg M, Durgerian S, Butts A, Hantke N, Lancaster M, Matthews MA, Rao SM (2012) Lifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy aging. Curr Alzheimer Res 9:436-446. CrossRef Medline
44. Yesavage JA, Brink TL, Rose TL, LumO, Huang V, Adey M, LeirerVO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37-49. CrossRef Medline